Lilly announced results from its Phase 3 TRIUMPH-4 trial of retatrutide, a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, on Thursday
All treatment plans are personalized based on your medical history, goals, and clinical evaluation
Stopping GLP-1 therapy in diabetic patients risks not only weight regain but also deterioration of blood sugar control, potentially requiring additional diabetes medications
Unequivocally, we do not see the same effects in humans as we do in rodents, says Elizabeth Pearce, MD, an endocrinologist and thyroid specialist at Boston Medical Center
~ AlphaMD Updated on July 23rd, 2025 When it comes to hormone optimization and fertility treatments, two commonly discussed medications are enclomiphene and human chorionic gonadotropin (HCG)
Excellent service My order was shipped promptly an quality was good Research Use Only This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications
